Azelastine is more potent than olopatadine in inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells
Authors:
- Theoharis C. TheoharidesTTTheoharis C. Theoharides
- 1 May 2002
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (5) , 501-506
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Olopatadine inhibits TNFα release from human conjunctival mast cellsAnnals of Allergy, Asthma & Immunology, 2000
- Inhibitory effects of azelastine hydrochloride in alcohol-induced asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Evaluation of Olopatadine, a New Ophthalmic Antiallergic Agent with Dual Activity, Using the Conjunctival Allergen Challenge ModelAnnals of Allergy, Asthma & Immunology, 1998
- Olopatadine (AL-4943A): Ligand Binding and Functional Studies on a Novel, Long Acting H1-Selective Histamine Antagonist and Anti-Allergic Agent for Use in Allergic ConjunctivitisJournal of Ocular Pharmacology and Therapeutics, 1996
- The In Vitro and In Vivo Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic AgentJournal of Ocular Pharmacology and Therapeutics, 1996
- The antiallergic effects of antihistamines (H1-receptor antagonists)Journal of Allergy and Clinical Immunology, 1992
- Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugsInflammation Research, 1985
- Antiallergic Drug Cromolyn May Inhibit Histamine Secretion by Regulating Phosphorylation of a Mast Cell ProteinScience, 1980
- Plasma membrane folds on the mast cell surface and their relationship to secretory activity.Journal of Cell Biology, 1977
- A procedure for the determination of histamineBiochimica et Biophysica Acta, 1961